Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      CCI investigation points to unfair practices by 3 pharma companies

      CCI investigation points to unfair practices by 3 pharma companies

      Medical Dialogues Bureau22 Sept 2018 5:44 PM IST
      New Delhi: Three prominent pharmaceutical companies are now under the radar of the Competition Commission of India (CCI) has started an initial...
      Sun Pharma gets Australia TGA nod for ILUMYA to treat plaque psoriasis

      Sun Pharma gets Australia TGA nod for ILUMYA to treat plaque psoriasis

      Medical Dialogues Bureau22 Sept 2018 12:38 PM IST
      ILUMYA used for the treatment of adults with plaque psoriasis. The program is designed to supplement the support offered by doctors in their practice...
      Aspen Pharma suffers week of woe as valuation tumbles by $3 billion

      Aspen Pharma suffers week of woe as valuation tumbles by $3 billion

      Medical Dialogues Bureau22 Sept 2018 9:42 AM IST
      The Aspen Pharma share price has tumbled more than 35 per cent since it posted full-year results and announced the baby milk disposal to French dairy...
      Takeda gets European panel nod for Alunbrig to treat lung cancer

      Takeda gets European panel nod for Alunbrig to treat lung cancer

      Medical Dialogues Bureau22 Sept 2018 9:33 AM IST
      The European Medicines Agency's Committee for Medicinal Products for Human Use recommended granting Japan-based Takeda's Alunbrig, or brigatinib, a...
      Soon Indian Standard for medical devices, says VK Paul

      Soon Indian Standard for medical devices, says VK Paul

      Medical Dialogues Bureau21 Sept 2018 1:37 PM IST
      New Delhi: A range of medical devices, old or new, will soon have an 'Indian standard' and nearly 1,000 products are presently being benchmarked, a...
      Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

      Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

      Medical Dialogues Bureau21 Sept 2018 1:32 PM IST
      Investment firm KKR, through its portfolio company Radiant Life Care Private Limited, will buy more than 266 million shares in Max Healthcare at Rs 80...
      Australian Competition and Consumer Commission clears Arrow ,Apotex merger: Strides

      Australian Competition and Consumer Commission clears Arrow ,Apotex merger: Strides

      Medical Dialogues Bureau21 Sept 2018 1:15 PM IST
      Strides Pharma Science Thursday said the Australian Competition and Consumer Commission (ACCC) has decided not to oppose the merger of generic pharma...
      ICRA upgrades long-term credit rating of Fortis Healthcare

      ICRA upgrades long-term credit rating of Fortis Healthcare

      Medical Dialogues Bureau21 Sept 2018 1:01 PM IST
      New Delhi: Fortis Healthcare Thursday said rating agency ICRA has upgraded its long-term credit rating as it has repaid the overdue debt obligations...
      AstraZeneca plots China robot offensive to counter price cuts

      AstraZeneca plots China robot offensive to counter price cuts

      Medical Dialogues Bureau21 Sept 2018 9:02 AM IST
      WUXI, China/LONDON: With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest...
      EU approves fifth copy of AbbVie

      EU approves fifth copy of AbbVie's $18 Billion drug Humira

      Medical Dialogues Bureau21 Sept 2018 9:00 AM IST
      LONDON: Europe has approved a fifth copy of AbbVie's $18-billion-a-year biologic drug Humira - the world's best-selling prescription medicine -...
      Paras Healthcare appoints Devendra Kumar Punia as Corporate Head - IT

      Paras Healthcare appoints Devendra Kumar Punia as Corporate Head - IT

      Medical Dialogues Bureau20 Sept 2018 3:17 PM IST
      In this new journey as Head- IT in Paras healthcare group, my strengths and responsibilities will rely on leveraging more data resources to deliver...
      California: Drugmaker paid doctors to overprescribe Humira

      California: Drugmaker paid doctors to overprescribe Humira

      Medical Dialogues Bureau20 Sept 2018 1:52 PM IST
      Pharmaceutical giant AbbVie illegally plied doctors with cash, gifts, and services to prescribe one of the world's best-selling drugs, Humira, despite...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok